Method of treatment of hypoxia inducible factor (HIF)-related conditions
USRE50230E1 · kind E1 · reissue
0Cited by
8References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 25, 2022 |
| Grant date | Dec 10, 2024 |
| Priority date | — |
| Expiry date | May 25, 2042 |
Classification
- Technology area (CPC —)General
Abstract
The present invention relates to methods of treatment of Hypoxia Inducible Factor (HIF)-related conditions, and in particular to methods of treatment of HIF-related conditions comprising the administration of a composition comprising transferrins.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.